Avantor, Inc. (NYSE:AVTR) Shares Sold by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB lowered its stake in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 18.5% in the third quarter, Holdings Channel reports. The institutional investor owned 25,500 shares of the company’s stock after selling 5,800 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Avantor were worth $660,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in AVTR. 1832 Asset Management L.P. grew its position in shares of Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after buying an additional 8,038,451 shares in the last quarter. CCLA Investment Management boosted its holdings in Avantor by 147,220.3% in the first quarter. CCLA Investment Management now owns 4,720,144 shares of the company’s stock worth $120,828,000 after purchasing an additional 4,716,940 shares during the period. Sound Shore Management Inc. CT acquired a new position in Avantor in the second quarter worth $76,412,000. Canada Pension Plan Investment Board boosted its holdings in Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after purchasing an additional 1,463,695 shares during the period. Finally, Magnetar Financial LLC acquired a new position in Avantor in the first quarter worth $35,154,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

Shares of AVTR opened at $22.43 on Friday. Avantor, Inc. has a one year low of $16.63 and a one year high of $28.00. The stock’s fifty day moving average is $25.49 and its 200-day moving average is $24.26. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The firm has a market capitalization of $15.24 billion, a price-to-earnings ratio of 57.51, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Friday, October 25th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.01. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.72 billion. Equities analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Robert W. Baird lifted their price objective on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Evercore ISI decreased their price objective on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. UBS Group decreased their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Finally, Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and an average price target of $27.79.

Get Our Latest Analysis on AVTR

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.